posted on 2021-07-13, 14:11authored byPierre J Saulnier, Helen C Looker, Michael Mauer, Behzad Najafian, Elise Gand, Stephanie Ragot, Robert G Nelson, Petter Bjornstad
No longitudinal data link intraglomerular hemodynamic
dysfunction with end-stage kidney disease (ESKD) in people with type 2 diabetes
(T2D). Afferent (RA) and efferent (RE) arteriolar tone
and intraglomerular pressure (PGLO) are not directly measurable in humans
but are estimable from glomerular filtration rate (GFR), renal plasma flow
(RPF), blood pressure, hematocrit, and plasma oncotic pressure. We examined the
association of the RA/RE ratio and PGLO
with ESKD incidence in 237 Pima Indian persons with T2D who underwent serial measures
of GFR (iothalamate) and RPF (p-aminohippurate). Their association with
kidney structural lesions was also examined in a subset of 111 participants.Of the 237 participants
(mean age 42 years, diabetes duration 11 years, GFR 153 ml/min, median ACR 36
mg/g), 69 progressed to ESKD during median follow-up of 17.5 years. In latent
class analysis, distinct trajectories characterized by increasing RA/RE
ratio (HR: 4.60, 95% CI 2.55-8.31) or elevated PGLO followed by a
rapid decline (HR: 2.96, 95% CI 1.45-6.02) strongly predicted incident ESKD. PGLO
(R2=21%, p<0.0001) and RA/RE (R2=15%,
p<0.0001) also
correlated with mesangial fractional volume, a structural predictor of DKD
progression.In conclusion, intraglomerular hemodynamic parameters associated
strongly with incident ESKD and correlated with structural lesions of DKD.
Funding
Financial support for this work provided by the American Diabetes Association (Clinical Science Award 1-08-CR-42) and by the Intramural Research Program of the NIDDK. P.B. receives salary and research support from NIDDK (DK116720, DK114886), JDRF (2-SRA-2019-845-S-B, 3-SRA-2017-424-M-B), Boettcher Foundation, Center for Women’s Health Research at University of Colorado, the Department of Pediatrics, Section of Endocrinology and Barbara Davis Center for Diabetes at University of Colorado School of Medicine.